CHEK2 variants associate with hereditary prostate cancer. - Wikidata - awgldk - TriplyDB

CHEK2 variants associate with hereditary prostate cancer.

CHEK2 variants associate with hereditary prostate cancer.

http://www.wikidata.org/entity/Q36671622

about

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women The CHEK2 gene and inherited breast cancer susceptibility PALB2 variants in hereditary and unselected Finnish prostate cancer cases.Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant.Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer The checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN).CHEK2 is a multiorgan cancer susceptibility gene.CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance.ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer Rapid Detection Method for the Four Most Common CHEK2 Mutations Based on Melting Profile Analysis CHEK2 mutation and risk of prostate cancer: a systematic review and meta-analysis.An inherited NBN mutation is associated with poor prognosis prostate cancer ATM polymorphisms as risk factors for prostate cancer development.A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer.In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2.A personalised approach to prostate cancer screening based on genotyping of risk founder alleles Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers Selected aspects of inherited susceptibility to prostate cancer and tumours of different site of origin.Mice with the CHEK2*1100delC SNP are predisposed to cancer with a strong gender bias.Multiple primary cancers as a guide to heritability.Hereditary breast cancer syndromes and genetic testing.Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.Germline copy number variation analysis in Finnish families with hereditary prostate cancer.Pilot study on low penetrance breast and colorectal cancer predisposition markers in latvia.CHEK2 I157T associates with familial and sporadic colorectal cancer.The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients.Alternative splicing and mutation status of CHEK2 in stage III breast cancer.Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.CHEK2 mutations and the risk of papillary thyroid cancer.Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort.CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden.

P2860

Q22000758-45932C3A-851F-44FD-B42B-8B6BD884ADF6 Q24795977-52B006A6-FC67-4F23-9C00-0711623A1BD8 Q28265315-1E285D2D-E09C-42AE-9336-4B5B17D17568 Q33590262-FE500C38-166A-4546-828B-C14B63A70B52 Q33831941-F48D5791-AEED-460A-AD30-3BEAD47C477C Q34263742-A256AD57-67DF-4519-A8C8-9B7B527FF5D4 Q34478300-D46CFCEF-A0D1-41D8-A327-CF89A89D9761 Q34551970-950E7587-820F-4E58-A7B8-155D0061BB2B Q34560743-FEC55CD1-8E02-4EEF-A228-CF3EEE61D0AF Q34572576-FB0ACFC6-5BEC-4C48-B9CD-A530103F2829 Q34960835-DC9CE589-B566-421E-9167-D4CF3633D0E3 Q35794421-C0CDC40F-B802-49BE-91B0-0E069EF734B7 Q35933901-A3FA59BD-43D5-4164-9152-6147329E6ADA Q36113106-143687F1-C38B-484C-AD07-87D4D829E949 Q36303818-17FDDB20-7082-4007-BF37-F0F4A94EB477 Q36317649-470D4826-A3C4-445D-A4BA-B80F091E44FD Q36594121-575A9FD1-A0EA-43B8-BA0C-E610EA92B36E Q36626035-13358502-A4EE-484C-B86C-56228DE57BF1 Q36927109-C72CBCE3-EAEE-4341-8B6E-405793F797E3 Q36944044-A0E1238A-8FEA-4308-A2B9-92C6AA761239 Q36959139-19900B35-F5C7-4AE3-B622-E3FDC55F2976 Q37195960-1332D1EB-A52E-45A3-A66A-182F0FF99317 Q37272989-37699CEF-0B7D-462A-89FB-5D07725B8FE6 Q37331110-3B309677-D14B-4A54-A046-4574131CAE22 Q37386101-C9381065-CE13-41A8-A287-DA9E24FD75DC Q38221583-0D83A360-B4F4-44AB-A139-519ABE122345 Q38266306-AFB26913-29B6-4073-BA50-260AFF03EC7F Q39398050-74EAFFF9-9BC3-4CF6-9F13-FEF4680095B4 Q40383603-EC884157-C2C9-46D4-B01B-19856F610C31 Q41137258-13F9FE71-CD27-4C77-B26C-D3E8B72FA44D Q42244975-455FEC8F-E994-43E9-86FD-DBA3F5A33A12 Q43169381-C51805AE-2366-4E05-913A-2EC7142A072B Q44733776-79DC1897-D1D6-4FB0-BC95-529259E6D2E2 Q45097069-9C1E9045-D648-406E-B45C-D475399A4C63 Q48173616-F4A8356C-9E86-4C7C-8C8B-DDD8F9692AA1 Q52566012-63285525-1376-4B06-B67C-E9813DF92854 Q52586097-029AC778-C592-45B5-A7F6-BC5D6B4135D1 Q52976068-B070A683-6C02-416B-8706-300D45B4E102 Q53286223-4808BF06-E6D8-46C2-B8AD-FA92A3449918 Q53638334-74A723BA-1EF8-4A7D-8721-3CF9279A4435

P2860

CHEK2 variants associate with hereditary prostate cancer.

http://www.wikidata.org/entity/Q36671622

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

CHEK2 variants associate with hereditary prostate cancer.

@ast

CHEK2 variants associate with hereditary prostate cancer.

@en

type

label

CHEK2 variants associate with hereditary prostate cancer.

@ast

CHEK2 variants associate with hereditary prostate cancer.

@en

prefLabel

CHEK2 variants associate with hereditary prostate cancer.

@ast

CHEK2 variants associate with hereditary prostate cancer.

@en

P1433

Q36671622-C1311B25-8624-4A10-B948-3F238ADB0636

P1476

Q36671622-45F2CE33-836F-4D33-96ED-F4B670D5A2A8

P2093

Q36671622-3E632E3C-F5C0-4827-B83E-4B7C300975DA

Q36671622-4D67993A-5CB5-4E7C-B696-802BCDB1DE3A

Q36671622-5A46ACFF-9195-40B2-8A1A-D788F6DE880D

Q36671622-6752A942-B9A0-48C3-9D0C-E128A5C1EBF8

Q36671622-87927248-DEAA-4829-847A-2704D7C12C16

Q36671622-A052BD5D-E39E-44BF-B10C-0017AAA8686A

Q36671622-A805EB31-6A6E-4EFF-B50B-5D91E2563ACB

Q36671622-C8D6051C-6701-4B11-8AA8-58577BA1E47B

P2860

Q36671622-088D24E6-BCCF-4E97-82E3-995165C1775B

Q36671622-23C99049-6C7F-4DE6-AF9F-125BD8B5A4A5

Q36671622-3B27E84C-ED4A-4BAD-8C61-F9AEA532281A

Q36671622-3CD73809-6F62-400E-941B-302D3992DA83

Q36671622-41392FE3-20D1-4252-8468-039A9DE7476B

Q36671622-4F5685C1-63B8-4129-BBF2-36A4F188884C

Q36671622-51FB0721-3515-4EC4-AC39-E5E3F65F0A4F

Q36671622-56431F72-8A53-4E98-A6E6-C149E0744E86

Q36671622-7683DFF2-266E-4845-B1BC-A75647A55AE0

Q36671622-78F8DFE8-57A1-46B1-88D8-CE9F0056648E

P2888

Q36671622-307202C8-0AD1-419C-B1ED-235FB4773034

P304

Q36671622-DF4A00BE-2734-421C-8A61-CA743CD7ACFE

P31

Q36671622-C11BA634-4743-4859-A042-DCB3FF8CB62A

P356

Q36671622-699487AD-C796-4FDE-A76E-B24DF9A4DE87

P407

Q36671622-89E78955-66A3-4C4D-8719-08A2E2E06735

P433

Q36671622-9E17F863-19EA-4336-BD9B-AC3D07B4525E

P478

Q36671622-C2A1201E-296A-448F-A345-63FC068E4821

P577

Q36671622-190BE691-ABC3-4516-B162-E09F8C26E35E

P5875

Q36671622-6083C3FB-BAF3-49C4-9E7F-6677F2F54740

P6179

Q36671622-99B76BBB-DA3A-4999-A55D-3D00790C3EBE

P698

Q36671622-0EADFA78-5205-4249-B0A4-62FD3155CBD2

P932

Q36671622-4132492C-8927-4B1E-BF86-9C246F4D714D

P356

P1433

British Journal of Cancer

P1476

CHEK2 variants associate with hereditary prostate cancer.

@en

P2093

Autio V

http://www.w3.org/2001/XMLSchema#string

Ikonen T

http://www.w3.org/2001/XMLSchema#string

Matikainen MP

http://www.w3.org/2001/XMLSchema#string

Mononen N

http://www.w3.org/2001/XMLSchema#string

Rökman A

http://www.w3.org/2001/XMLSchema#string

Schleutker J

http://www.w3.org/2001/XMLSchema#string

Seppälä EH

http://www.w3.org/2001/XMLSchema#string

Tammela TL

http://www.w3.org/2001/XMLSchema#string

P2860

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

A candidate prostate cancer susceptibility gene at chromosome 17p

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility

Use of population isolates for mapping complex traits.

Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease.

P2888

P304

1966-1970

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601425

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9012873

http://www.w3.org/2001/XMLSchema#string

P6179

1052868427

http://www.w3.org/2001/XMLSchema#string

P698

14612911

http://www.w3.org/2001/XMLSchema#string

P932

2394451

http://www.w3.org/2001/XMLSchema#string